Biogen Inc (BIIB)

190.73 -2.25%

Biogen Inc (BIIB) is currently trading at $190.73. This represents a loss of 2.25% from the previous session. With a market capitalization of $27.99B, BIIB is a key component of the Health Care sector. Investors looking to trade BIIB should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade BIIB commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Biogen Inc (BIIB) shows a bearish trend. Analysts are watching the 196.73 level closely.

Fundamentals
Mkt Cap27.99B
P/E Ratio0.0000
Volume942,723
Others Watching (By Market Cap)
CAH
Cardinal Health $226.18
+0.09% IDXX
IDEXX Laborator $657.38
+1.26% BDX
Becton Dickinso $180.96
-0.84% EW
Edwards Lifesci $83.40
+1.21% ALNY
Alnylam Pharmac $327.14
-1.72%
60-Day Technical Chart
Advanced Charting

Need more indicators for BIIB? Use the world's #1 platform.

Open BIIB on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $191
Metric BIIB
-2.25% 		NVDA
+1.44% 		COIN
+13.52% 		CRM
+3.41%
Price $190.73 $195.63 $183.94 $191.75
Mkt Cap $27.99B $4,753.69B $48.57B $179.67B
- View → View → View →
Latest Headlines
Biogen Stock After Alzheimer’s Shake-Up: Bargain or Value Trap? AD HOC NEWS • Feb 26, 2026 Biotech CEO behind RNA Dravet drug joins TD Cowen conference lineup Stock Titan • Feb 24, 2026 Biogen (BIIB) Stock Is Up, What You Need To Know Yahoo Finance • Sep 2, 2025 How One Drug Heavy-Lifted Biogen's Fourth-Quarter Beat Investor's Business Daily • Feb 6, 2026 Why Biogen Stock Surged Almost 9% Higher on Friday The Motley Fool • Feb 6, 2026
● Gemini Agentic AI Analyst Insight for BIIB
Market Education
View All Articles →
External Research